Authors find no link between engraftment microbiome diversity and non-relapse mortality
The authors of a Phase III trial published in Nature Medicine reported no association between engraftment microbiome diversity and non-relapse mortality after 1 year (P = 0.314). They also found that lower baseline microbiome diversity was associated with shorter overall survival (P = 0.007).
Primary source
PubMed record of a Phase III journal article, November 13, 2026
Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial.
Read the source: Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial. pubmed.ncbi.nlm.nih.gov
Machine-summarized from the source above; not independently reported. How we use automation